Financial Performance - The company reported a basic earnings per share of 0.0040 yuan, a significant increase of 104% compared to -0.1000 yuan in the previous year [1] - Operating revenue reached 4.59 billion yuan, marking a 33.82% increase from 3.43 billion yuan in the prior year [1] - Net profit improved to 0.01 billion yuan, a 102.5% increase from a loss of 0.4 billion yuan in the previous year [1] - The return on equity rose to 0.18%, a substantial improvement from -4.75% in the previous year [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 15,284.51 million shares, accounting for 36.97% of the circulating shares, with a decrease of 1,236.11 million shares compared to the previous period [1] - Tianjin Weixin Yangguang Enterprise Management Consulting Co., Ltd. remains the largest shareholder with 7,185.94 million shares, representing 17.38% of total share capital [2] - New entrants to the top ten shareholders include Wang Ning with 497.71 million shares and Tianjin Yangguang Fuyue Enterprise Management Partnership with 367.75 million shares [2] Dividend Policy - The company has decided not to distribute dividends or increase capital [2]
赛诺医疗:2024年报净利润0.01亿 同比增长102.5%